How will Asia tackle total drug resistant TB?

The latest concern to have plagued the field of tuberculosis (TB) is the emergence of total drug resistant TB (TDR-TB). ...

March 23, 2012 | Friday | News
BioSpectrum announces the hits and misses of 2013

Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase i...

January 2, 2014 | Thursday | Analysis
“Many foreign CROs are often hesitant to make big investments in Japan”

Founded in 1983, BBK Worldwide is a marketing consultancy firm specializing in patient recruitment for clinical R&D ...

August 14, 2015 | Friday | Opinion
Takeda collaborates with Keio University

Singapore: Japanese pharma major, Takeda Pharmaceutical Company has signed an agreement to undertake collaborative resea...

April 23, 2015 | Thursday | News
FDA approves additional indication of Eisai's anticancer agent Lenvima

Japan's Eisai Co Ltd has announced that its US subsidiary Eisai Inc. has received approval from the US Food and Drug Adm...

May 17, 2016 | Tuesday | News
PharmaMar seeks Japan PMDA approval for tissue sarcoma drug

The Japanese Pharmaceutical Affairs and Food Sanitation Council (PAFSC) has recommended an approval for Madrid-based Pha...

September 2, 2015 | Wednesday | News
Treatment for rare metabolic disorder approved in Japan

NASDAQ-listed Alexion Pharmaceuticals Inc. has announced that Japan's Ministry of Health, Labour and Welfare (MHLW) appr...

July 7, 2015 | Tuesday | News
ILS strengthens Bachem's peptide business in Japan

Tokyo: Switzerland's Bachem and Initiative for Life Sciences (ILS) have decided to strengthen their co-marketing efforts...

September 9, 2015 | Wednesday | News
Japan to provide medical assistance to Kyrgyzstan

Singapore: In a bid to improve medical services and healthcare scenario in Kyrgyzstan, Japan has inked a pact with five ...

March 9, 2015 | Monday | News
Astellas sells Kiyosu Plant business to MicroBiopharm Japan

Tokyo: Pharma giant Astellas Pharma Inc. has announced that the company and MicroBiopharm Japan Co. Ltd. (MBJ) have conc...

November 2, 2015 | Monday | News
“Engineered 3D human tissue will bring efficiencies in drug screening and drug safety testing”

First, could you give the readers a short bio of your company?Cyfuse is a regenerative medicine startup founded in 2010 ...

June 30, 2015 | Tuesday | Opinion
OxOnc, Pfizer drug trial to be held in Asia

Singapore: OxOnc Development, an oncology development company founded by pharmaceutical development executives and oncol...

February 11, 2013 | Monday | News
Invivoscribe, Astellas sign agreement for companion diagnostics

Invivoscribe Technologies Inc., a US-based company with international experience in commercializing in-vitro diagnostic ...

April 29, 2015 | Wednesday | News
Japan Pharma Manufacturers Association partners with Medidata

Singapore: Medidata, a provider of cloud-based solutions for clinical research, has collaborated with Japan Pharmaceutic...

September 1, 2015 | Tuesday | News
Takeda partners with WIPO to accelerate R&D

Singapore: Japan based Takeda Pharmaceutical has participated in WIPO Re:Search, a consortium to accelerate research and...

April 24, 2016 | Sunday | News
CPhI Japan set to begin tomorrow

Singapore: CPhI Japan, organized by UBM EMEA, is set to begin at the Big Sight Exhibition Center, Tokyo, Japan, from Apr...

April 21, 2015 | Tuesday | News
Astella, Potenza partner to enhance immune-oncology programs

Singapore: Japan's Astellas Pharma and Potenza Therapeutics, a biotechnology company developing a portfolio of immuno-on...

April 23, 2015 | Thursday | News
Tosoh buys an Indian invitro diagnostics company

Singapore: As part of expanding and strengthening its bioscience operations, Japan-based Tosoh Corporation has acquired ...

April 21, 2015 | Tuesday | News